CREME PARA PREVENÇÃO DE ESTRIAS
A nanotechnology-based cream with specific ingredients addresses the inadequacies of existing stretch mark creams by enhancing hydration, firmness, and elasticity, effectively preventing stretch marks in diverse skin tones and age groups, especially benefiting pregnant women with black skin.
Patent Information
- Application Number
- BR102025008903
- Authority / Receiving Office
- BR · BR
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2025-05-05
- Publication Date
- 2026-11-10
AI Technical Summary
Existing skin creams for stretch mark prevention do not effectively address the needs of pregnant women with black skin, particularly in terms of hydration, firmness, elasticity, tissue regeneration, and skin recovery, and are not tailored for diverse skin tones and age groups.
A nanotechnology-based cream composed of specific ingredients in precise percentages, including water, pemulen TR2, edta, allantoin, hydroxyethylcellulose, cetostearyl alcohol, caprylic/capric triglycerides, tinogard TT, octyl stearate, amphisol K, murumuru butter, vitamin E, castor oil, pracaxi oil, andiroba oil, zemea, hydrovance, nano rose hips, nv skin healthier eco, vanilla lavender essence, structure xl, dry flo pc, tapioca pure, and lactic acid, formulated to enhance skin absorption and provide hydration, firmness, and elasticity, with phases of mixing and heating to ensure homogeneity.
The cream effectively prevents stretch marks by enhancing skin hydration, firmness, and elasticity, promoting tissue regeneration and recovery, suitable for all skin tones and age groups, particularly benefiting pregnant women with black skin.
Description
1 / 4 “CREAM FOR PREVENTING STRETCH MARKS”.
[001] This Invention Patent refers to an innovative cream intended for the prevention of stretch marks on the skin, using nanotechnology processes for better skin absorption. This product was developed especially for pregnant women with black skin, but its benefits extend to people of all skin tones and in any age group, providing greater hydration, firmness and elasticity to the skin, regenerating tissues and promoting skin recovery and protection.
[002] In order to ascertain the content of the state of the art relating to the present subject, searches were carried out in the available patent databases, which resulted in three documents that can provide a comparative overview in relation to the present application.
[003] Document BR1120120311174, filed on 08 / 06 / 2011 and entitled “METHOD FOR SKIN ANTI-AGING TREATMENT AND KIT FOR SKIN ANTI-AGING TREATMENT”, refers to a method for skin anti-aging treatment comprising the administration of botulinum toxin to an area of skin on the face and / or neck combined with the administration of a cosmetic or pharmaceutical composition comprising a cosmetically or pharmaceutically effective amount of at least one SNAP-25 protein-derived peptide and / or at least one enkephalin-derived peptide, and at least one cosmetically or pharmaceutically acceptable excipient or adjuvant.
[004] Document WO2013044251, filed on 24 / 09 / 2012 and entitled “ANTI-STRETCH MARK SKIN CREAM AND METHOD FOR MAKING AND USING THEREOF”, refers to a skin cream and a method for making and applying the skin cream having, for example, a copper component, an ascorbic acid component, a lipid component and a peptide component. The peptide component may include Petition 870250105596, dated 11 / 18 / 2025, page 5 / 8 2 / 4 palmitoyl pentapeptide (KTTLS) or hydrolyzed sericin. The copper component may be a copper-solubilizing formulation. The copper-solubilizing formulation may include one of (i) copper and a copper-complexing peptide and / or (ii) a copper-complexing protein. The combination of copper and the ascorbic acid component may prevent or reduce destabilization of the ascorbic acid component.
[005] Document US10758473, filed on 03 / 23 / 2018 and entitled “EXTRACT OF PLANT ORIGIN OF GLOBULARIA AND METHOD FOR OBTAINING SAID EXTRACT BY IN VITRO PLANT CULTURE”, refers to an extract of the genus Globularia obtained from a plant of the genus Globularia, used for a non-therapeutic cosmetic treatment of the skin and / or appendages. Preferably, the species is Globularia cordifolia and the extract is obtained by in vitro plant culture.The extract can be used to prevent and / or treat skin aging by stimulating detoxification and cellular regeneration reactions through a hormetic-type response, to improve skin transparency and radiance, to prevent or treat sensitive and reactive skin, to prevent or treat redness, to prevent protein glycation, to increase and / or maintain the number of dermal stem cells, to increase and / or maintain dermal macromolecules, particularly collagen and elastin, to increase dermal volume, to prevent and / or treat fine lines and wrinkles, to firm the skin, to prevent hair loss and / or stimulate hair growth. The invention also relates to a method of obtaining the extract by in vitro plant culture of undifferentiated Globularia cells and to a plant-derived extract that can be obtained from them.
[006] As can be seen, none of the documents found report technical characteristics that conflictingly anticipate the content of this request. Petition 870250105596, dated 11 / 18 / 2025, page 6 / 8 3 / 4
[007] In order to surpass and differentiate itself from the state of the art, the present “CREAM FOR THE PREVENTION OF STRETCH MARKS” was developed, which will henceforth be referred to simply as “CREAM”.
[008] In the present “CREAM”, in percentage, it is composed, according to the phases of the production process, by, in phase 1, water (50.35%), pemulen TR2 (0.25%), edta (0.1%) and allantoin (0.3%); in phase 2, hydroxyethylcellulose (0.2%); in phase 3, cetostearyl alcohol 30 / 70 (6%), caprylic / capric triglycerides (4%), tinogard TT (0.1%), octyl stearate (3%) and amphisol K (0.5%); in phase 5, murumuru butter (2%); in phase 6, vitamin E (0.5%), castor oil (0.5%), pracaxi oil (1.5%) and andiroba oil (1.5%); in phase 7, zemea (5%) and hydrovance (3%); in phase 8, water (5%), potassium sorbate (0.35%) and sodium benzoate (0.35%); in phase 9, nano rose hips (5%) and nv skin healthier eco (5%); in phase 10, vanilla lavender essence (0.3%); in phase 11, structure xl (2%); in phase 12, dry flo pc (2%) and tapioca pure (1%) and, in phase 13, lactic acid (0.2%).
[009] According to the production process of the present “CREAM”, phase 1 should be poured into the production tank and heating should begin with slow agitation. After phase 1 is completely solubilized, phase 2 should be poured in under constant agitation, maintaining heating. After reaching 74°C, phase 3 should be poured in, maintaining heating until 80°C and swirling to completely melt the waxes. With the product homogeneous, cooling should begin and, at 50°C, phase 5 should be added. Cooling should be maintained and, below 45°C, swirling should cease and phase 6 should be poured in, followed by phase 7. In a separate container, phase 8 should be solubilized. With the product below 40°C in the production tank, phase 8 should be poured in, being duly solubilized. Phase 9 should be added, followed by Phase 10. Under intense agitation, Phase 11 should be added.After it has become completely homogeneous, add phase 12, stir for a few minutes, and check the pH to adjust it with phase 13 if necessary. Petition 870250105596, dated 11 / 18 / 2025, page 7 / 8 4 / 4
[0010] In conclusion, it can be stated that the present “CREAM FOR "PREVENTION OF STRETCH MARKS", due to its set of technological innovations, fully meets the conditions to apply for the granting of an Invention Patent. Petition 870250105596, dated 11 / 18 / 2025, page 8 / 8
Claims
1 / 2 CLAIMS 1a. “CREAM FOR PREVENTION OF STRETCH MARKS”, characterized by being composed, according to the phases of the production process, of, in phase 1, water (50.35%), pemulen TR2 (0.25%), EDTA (0.1%) and allantoin (0.3%); in phase 2, hydroxyethylcellulose (0.2%); in phase 3, cetostearyl alcohol 30 / 70 (6%), caprylic / capric triglycerides (4%), Tinogard TT (0.1%), octyl stearate (3%) and amphisol K (0.5%); in phase 5, murumuru butter (2%); in phase 6, vitamin E (0.5%), castor oil (0.5%), pracaxi oil (1.5%) and andiroba oil (1.5%); in phase 7, zemea (5%) and hydrovance (3%); in phase 8, water (5%), potassium sorbate (0.35%) and sodium benzoate (0.35%); in phase 9, nano rose hips (5%) and nv skin healthier eco (5%); in phase 10, vanilla lavender essence (0.3%); in phase 11, structure xl (2%); in phase 12, dry flo pc (2%) and tapioca pure (1%) and, in phase 13, lactic acid (0.2%). 2a) “CREAM FOR PREVENTION OF STRETCH MARKS”, according to claim 1, characterized in that, according to its production process, in the production tank, phase 1 should be poured in and heating should begin with slow agitation; after phase 1 is completely solubilized, phase 2 should be poured in under constant agitation, maintaining heating; after reaching 74°C, phase 3 should be poured in, maintaining heating until 80°C and swirling for complete fusion of the waxes; with the product homogeneous, cooling should begin and, at 50°C, phase 5 should be added; cooling should be maintained and, below 45°C, swirling should cease and phase 6 should be poured in, followed by phase 7; in a separate container, phase 8 should be solubilized; with the product below 40°C in the production tank, phase 8 should be poured in, being duly solubilized; Phase 9 should be poured in, followed by Phase 10; under intense agitation, Phase 11 should be poured in.After it is completely homogeneous, phase 12 should be added, with stirring for a few minutes and checking the pH to, if necessary, adjust with phase 13. (Petition 870250036012, dated 05 / 05 / 2025, page 9 / 12 2 / 2)
